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doi:10.1016/j.kjms.2011.06.008Abstract Spontaneous pneumothorax occurs less in females than in males, in contrast to the
relatively more commonly and incidentally found renal angiomyolipoma (AML). We report
a renal AML in a 23-year-old female patient, which presented as right palpable abdominal
mass. This renal tumor was removed owing to enlargement and internal hemorrhage and
AML was proved by pathological examination. Three years later, she experienced a life-
threatening spontaneous tension pneumothorax and pulmonary lymphangioleiomyomatosis
(LAM), which was diagnosed by chest computed tomography. Clinically, she did not have
tuberous sclerosis. Pulmonary LAM and renal AML are related lesions and both of these prolif-
erative lesions occur in sporadic patients without family history and at much higher frequency
in patients with tuberous sclerosis. Because of the nonspecific symptoms and high rate of
complications, we should consider the possibility of LAM in patients diagnosed with AML.
The association between renal AML and pulmonary LAM is reviewed.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.Introduction
Pulmonary lymphangioleiomyomatosis (LAM) is a rare debil-
itating disease, predominantly affecting women of child-
bearing age. The disorder runs a variable course leading to
respiratory failure [1]. Extrapulmonary manifestations inNephrology, Department of
niversity Hospital, 100 Shih-
an.
.tw (M.-C. Kuo).
vier Taiwan LLC. All rights reservLAM include renal angiomyolipomas (AMLs) (54%), enlarged
abdominal lymph nodes (39%), and lymphangiomyomas
(16%) [2]. Renal AML is frequently found incidentally when
a patient receives renal sonography examination. However,
most clinicians will consider the possibility of the coexis-
tence of renal AML and pulmonary LAM, and thus some
patients might develop the life-threatening complication of
pneumothorax. We report a young woman in whom AML was
diagnosed 3 years before the diagnosis of pulmonary LAM
complicated with pneumothorax. The literature on the
association between LAM and AML is also reviewed.ed.
Figure 2. Chest X-ray shows free air in the right pleural
cavity, compatible with right tension pneumothorax.
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A 23-year-old healthy female suffered from right flank pain,
epigastralgia, nausea, vomiting, and general weakness for
2 days in October 2002. No fever or urinary discomfort was
noted, but physical examination revealed right upper
quadrant tenderness and a palpable right abdominal mass.
The abdominal sonography showed high echoic right renal
tumor and the abdominal computed tomography (CT) scan
demonstrated a 11 cm 6.2 cm 13 cm well-defined, well-
enhanced heterogeneous mass lesion containing fat in right
kidney, which suggested a renal AML. She refused further
angiographic study or surgical intervention initially because
no severe symptoms were noted. Follow-up abdominal
magnetic resonance imaging in September 2003 and
January 2004 also revealed a huge lobulated mass with fat
component (11 cm 7.2 cm 14.4 cm) at low pole of right
kidney and a 2 cm nodular lesion at upper pole of left
kidney. However, follow-up abdominal magnetic resonance
imaging in November 2004 and abdominal CT in January
2005 demonstrated interval enlargement of right renal
fatty tumor (Fig. 1A and B). AML with hemorrhage was
suspected, so right radical nephrectomy was performed in
January 2005. By macroscopic examination, the kidney was
largely replaced by a well-circumscribed tumor, measuring
18.2 cm 15 cm 6.5 cm. From microscopic finding, the
tumor was composed of thick-walled poorly organized blood
vessels, mature adipose tissue, and bundles of smooth
muscle cells, histologically corresponding to an AML. The
immunohistocheminal study demonstrated HMB 45(þ). She
was discharged in good condition without further informa-
tion concerning AML and any other condition.
In September 2005, the patient complained of right-side
chest pain and shortness of breath. Physical examination
found diminished breathing sounds over right lung field, and
chest radiography showed collapse of right lung (Fig. 2). A
right-sided tension pneumothorax was diagnosed and
a chest tube was inserted for 4 days with good results.
Chest CT presented multiple small hypodense cystic lesions
in bilateral lung, distributed throughout the central and
peripheral lung field (Fig. 3A and B) and pulmonary LAM wasFigure 1. (A) Follow-up magnetic resonance image (January 2
(B) Abdominal computed tomography (January 4, 2005) reveals intconsidered. No lung tissue biopsy was prescribed at that
time and no recurrent pneumothorax was noted during the
follow-up. However, with this life-threatening complica-
tion, she was educated and became alert to possible of
pneumothorax recurrence.
She delivered her baby in January 2008 without compli-
cations. Neither progressive dyspnea, pneumothroax, nor
chylous pleural effusions developed during pregnancy. She
underwent complete neurologic evaluation for possible
tuberculosis sclerosis. No meningioma or abnormal finding
was found on brain CT. Lung function test showed normal
ventilation without obstructive or restrictive pattern. The
family history was noncontributory, and there were no
clinical signs of tuberous sclerosis (TSC). Subsequent renal004) demonstrates the angiomyolipoma of the right kidney.
erval enlargement of the hypervascular right renal tumor.
Figure 3. (A) Chest computed tomography shows pneumothorax during chest tube insertion (arrow). (B) Subsequent pictures still
show multiple small hypodense cystic lesions in bilateral lung parenchyma, distributed throughout the central and peripheral lung
fields.
Renal angiomyolipoma and pulmonary lymphangiomyomatosis 471sonography demonstrated one small hyperechoic nodule,
which favored AML, with a slight increase in size but still
smaller than 4 cm (around 1e2 cm). In this patient, AML and
sporadic-type LAM were diagnosed. No genetic study was
arranged for her. She continued to have regular follow-up.Discussion
LAM is a rare disease of the lungs and lymphatics, which can
occur sporadically or in association with TSC. LAM almost
exclusively affects females, generally developing before
the menopause. The usual clinical symptoms are exertional
dyspnea, cough, and (recurrent) spontaneous pneumo-
thorax [3e8]. LAM patients decline lung function tests more
than the healthy individuals. The abdominal manifestations
include lymphadenopathy, cystic lymphatic masses (lym-
phangioleiomyomas), chylous ascites, and renal AML (a
benign tumour). Although lung biopsy in combination with
immunostaining for smooth muscle markers and HMB-45
remains the gold standard for diagnosis, high-resolution CT
may be pathognomic, in which case many physicians do not
necessarily resort to a lung biopsy. This strategy is reason-
able if the CT appearance is typical, and the history is fully
consistent with LAM [1]. In our patient, the spontaneous
pneumothorax and chest CT demonstrated multiple thin-
walled parenchymal cysts scattered throughout the lung
fields in an even distribution with normal intervening lung
parenchyma, compatible with LAM diagnosis. Furthermore,
the classical CT appearance and the AML, which are typical
manifestations of LAM, were noted. Thus, tissue biopsy was
not required [9].
LAM and AML are closely related diseases because they
are characterized by a hamartomatous proliferation of HMB-
45 positive smooth muscle cells [10]. AMLs are composed of
mature adipose tissue admixed with a tortuous vascular
component and bundles of smooth muscle cells, mostly
arranged around blood vessels. The smooth muscle cells ofAML differ from normal smooth muscle cells in that they
react (like LAM cells) with the monoclonal antibody HMB-45
[3,5].
Our patient did not have TSC symptoms or signs clini-
cally. As reported, two-thirds of the cases occur as a result
of sporadic mutations and will have no family history of the
disease [11]. In sporadic LAM, somatic mutations have been
found in LAM cells in the lungs, lymph nodes, and AMLs,
predominantly for TSC2 [12]. And to a lesser extent for
TSC1, suggesting that the disease generally develops
because of somatic mutations in TSC2. Somatic mutations
in the TSC2 gene with loss of heterozygosity are identified
in AML and pulmonary smooth muscle cells from patients
with LAM, suggesting that these mutations play a direct role
in the pathogenesis of pulmonary LAM [12e14]. In patients
with sporadic LAM, AMLs are usually unilateral, small, and
solitary, and they are restricted to the kidney, whereas in
patients with TSC-LAM they are more often larger, bilat-
eral, multiple, multiorgan (involving the spleen or liver),
and prone to hemorrhage [15].
No therapy has been proven to be beneficial to LAM,
although some studies support hormonal manipulation [10].
Oophorectomy, progestin therapy (high-dose medroxy-
progesterone acetate), tamoxifen, and luteinizing hormone-
releasing hormone analogs have been used. Oophorectomy
is not recommended in patients with LAM because of
morbidity and a lack of proven benefit [16e20]. Patients
with LAM appear to have somatic gene mutations in TSC
genes resulting in constitutive activation of the mammalian
target of rapamycin. Sirolimus suppresses mammalian target
of rapamycin signaling and improves lung function in some
LAM patients [21].
As mentioned above, AML is the most-frequent extrap-
ulmonary manifestation of LAM. Renal AMLs are present
in 32e60% of pulmonary LAM patients [22]. AML and LAM
are rare, genetically interrelated diseases. Patients with
LAM usually have nonspecific complaints and may present
only spontaneous pneumothorax as first diagnosis. Early
472 P.-H. Wu et al.detection of LAM in an AML patient is important because
delayed diagnosis may cause severe complications and
morbidity. However, early detection of lung lesion in LAM is
quite difficult because chest radiography may not able to
reveal any lesion. High-resolution chest CT remains a fast
and noninvasive tool to detect this disease. If LAM is highly
suspected from chest CT study, the risk of spontaneous
pneumothorax should be explained to the patient. Most
importantly, doctors, especially nephrologists and urolo-
gists, should keep in mind the possibility of LAM in patients
diagnosed with AML. Patient should also be informed about
the possible complications, so they may be alert to the
symptom of life-threatening pneumothorax.
In conclusion, although AML is found in women of
childbearing age, it is mandatory to consider the possible
existence of LAM. Careful clinical and molecular studies of
LAM are still needed to improve treatment and outcome in
this disease.References
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